Advocacy materials

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries - Journal Article

Peer-reviewed | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Littrell et al.: Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malaria Journal 2011 10:327.

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria- endemic countries - Journal Article

Peer-reviewed | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

O’Connell et al.: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malaria Journal 2011 10:326.

The potential of the private sector to promote the integration of rapid diagnostic tests for malaria into developing country health systems: a multi-country study - Presentation

Presentations | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Presented in July 2011 at the iHEA conference. 

The private sector role in the supply of antimalarial drugs: Evidence from ACTwatch & implications for initiatives to improve ACT access - Presentation

Presentations | Benin | Cambodia | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Presented in July 2011 at the iHEA conference. 

Monitoring supply and demand for antimalarials and RDTs: an update on ACTwatch

Presentations | Benin | Cambodia | DR Congo | Kenya | Madagascar | Nigeria | Tanzania | Uganda | Zambia | 2013

Presented by Stephen Poyer on behalf of the ACTwatch group at the 6th Pan-African Malaria Conference (MIM 2013) in Durban in October 2013. 

Trends in Antimalarial Drug Use in Africa

Peer-reviewed | Benin | DR Congo | Kenya | Madagascar | Nigeria | Tanzania | Uganda | Zambia | 2013

Flegg J.A. et al., Am. J. Trop. Med. Hyg., 89(5), 2013, pp. 857865 doi:10.4269/ajtmh.13-0129

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market

Peer-reviewed | Benin | Cambodia | DR Congo | Kenya | Madagascar | Myanmar | Nigeria | Tanzania | Uganda | Zambia | 2013

O’Connell et al., Malaria Journal 2013, 12:52 http://www.malariajournal.com/content/12/1/52

Oral Artemisinin Monotherapy (oral AMT) Products found in 2013 ACTwatch Outlet Surveys

Multi-country | Cambodia | DR Congo | Madagascar | Myanmar | Nigeria | Uganda | 2014

The table outlines all oral artemisinin monotherapy (oAMT) products found during 2013 ACTwatch surveys. Photos are included where available. Among 6 countries surveyed in 2013,  oral AMT was found to be available in the DRC, Cambodia, Myanmar, and Nigeria. No oral AMT was found in Madagascar or Uganda.

Providing Malaria Market Evidence through the ACTwatch Project

Multi-country | Cambodia | DR Congo | Nigeria | Uganda | 2014

This brochure describes how ACTwatch data can be used to monitor markets and provide evidence to guide policy-makers and programme managers.

DRC 2013 Outlet Survey Results - Brief

Briefs | DR Congo | 2015

This brief (in French) summarizes the results of the 2013 Outlet Survey conducted in the Democratic Republic of the Congo. 

Pages